Pharmaceutical APIs
Linagliptin
Active Pharmaceutical Ingredient — Neurology
Linagliptin is an oral DPP-4 inhibitor used for treatment of type-2 diabetes by enhancing incretin activity and improving glucose control.
- CAS Number
- 668270-12-0
- Therapeutic Area
- Neurology
- Drug Class
- Antidiabetics
- Molecular Formula
- C25H28N8O2
- Molecular Weight
- 472.54
- PubChem CID
- 10096043
RFQ / Inquiry
Request Linagliptin
Send a structured RFQ to APINEXA's coordination team — confidential, supplier-matched, audit-grade. Typical response in 24 business hours.